Science Explorer Back to mapMap
Discussion
Researcher · Hôpital de Jolimont · Belgium

Thierry Delaunoit

Thierry Delaunoit publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Colorectal Cancer Treatments and Studies, Neuroendocrine Tumor Research Advances and Colorectal Cancer Surgical Treatments.

ORCID 0000-0002-4746-2777 OpenAlex
World rank
#1,634,888
of 7,710,434 ranked researchers
Rank in Belgium
#14,997
of 67,186
Works
77
Citations
2k
Citations per work
25.9
h-index
21
i10-index 29Top 22% in Oncology
Thierry Delaunoit

What does Thierry Delaunoit research?

Thierry Delaunoit's work is mostly in Medicine (69%), Biochemistry, Genetics and Molecular Biology (6%).

Health Sciences: 53 works · 68.6% of their workMedicine: 53 works · 68.6% of their workOncology: 27 works · 34.5% of their workPulmonary and Respiratory Medicine: 9 works · 11.7% of their workSurgery: 8 works · 10.7% of their workEpidemiology: 5 works · 6.8% of their workPathology and Forensic Medicine: 4 works · 4.9% of their workEverything else: 19 works · 25.1% of their workLife Sciences: 5 works · 6.3% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 6.3% of their workCancer Research: 5 works · 6.3% of their workTHEIR WORKThierry Delaunoit77works
Life Sciences6%Health Sciences69%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine5368.6%
  2. Everything else1925.1%
    1. Biochemistry, Genetics and Molecular Biology56.3%
  1. 1Oncology34% of their works
  2. 2Pulmonary and Respiratory Medicine12% of their works
  3. 3Surgery11% of their works
  4. 4Epidemiology7% of their works
  5. 5Cancer Research6% of their works
  6. 6Pathology and Forensic Medicine5% of their works

Research topics

Which keywords describe Thierry Delaunoit's research?

The keywords of their largest research topics: Chemotherapy, Cetuximab, KRAS Mutations, Clinical Practice Guidelines, Survival Analysis, Adjuvant Chemotherapy, Molecular Characterization and Genetic Mutations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Chemotherapy442 topics
  2. Cetuximab331 topic
  3. KRAS Mutations331 topic
  4. Clinical Practice Guidelines222 topics
  5. Survival Analysis222 topics
  6. Adjuvant Chemotherapy212 topics
  7. Molecular Characterization212 topics
  8. Genetic Mutations182 topics
  9. Endoscopic Resection111 topic
  10. Gastric Cancer111 topic
  11. Neuroendocrine Tumors111 topic
  12. Pancreatic Neuroendocrine Tumors111 topic
  13. Preoperative Chemoradiotherapy111 topic
  14. Rectal Cancer111 topic
  15. Hereditary Syndromes101 topic
  16. Microsatellite Instability101 topic
  17. Cancer Genomics91 topic
  18. Mutational Signatures91 topic
  19. ALK71 topic
  20. Chemotherapy-Induced Peripheral Neuropathy71 topic
  21. Neuroblastoma71 topic
  22. Taxanes71 topic

Where does Thierry Delaunoit work?

Thierry Delaunoit's main affiliation in the publication record is Hôpital de Jolimont, Belgium.

How many publications and citations does Thierry Delaunoit have?

OpenAlex counts 77 works and 1,995 citations for Thierry Delaunoit, an h-index of 21, ranking #1,634,888 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Thierry Delaunoit. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.